On January/18/2021 I wrote about a drug from the pharmaceutical Eli Lilly testing a new drug for
Alzheimer’s patients, the study was performed with a small group of patients for a very short period of time.
Still give patients with Alzheimer’s and their families hope. We all know that more needs to be done, and more studies need to be performed, however, these study really brings good news for many.
The study, of course, isolated the patients and those patients have to fit the profile for the study along with many questions to be answered but is great news.
That success will be carrying a lot of weight especially because there was nothing like for a very long time.
Please reread our blog Good News For Alzheimer’s Patients @ www.HealthCareNewYork.net/blog and the New York Times Alzheimer’s Shows Promise in Small Trial at Nytimes.com